ARTICLE | Company News
Bioject deal
October 25, 2004 7:00 AM UTC
BJCT granted an undisclosed Japanese pharmaceutical company exclusive Japanese rights to its Iject needle-free drug delivery system for an undisclosed compound in exchange for upfront licensing and de...